| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
51,320,000 |
| Market
Cap: |
4.72(B) |
| Last
Volume: |
548,324 |
Avg
Vol: |
491,730 |
| 52
Week Range: |
$71.24 - $93.49 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P SMALLCAP 600 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 438 |
| Guru Rank Value : 3.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Haemonetics is a global healthcare company providing a suite of medical products and solutions for customers. Co.'s technology addresses medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Co. has three principal reporting segments: Plasma, which provides automated plasma collection and donor management software systems; Blood Center, which provides a range of solutions that improve donor collection centers' ability to collect and filter blood and separate blood components; and Hospital, which has four product lines, including Hemostasis Management, Vascular Closure, Transfusion Management and Cell Salvage.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
22,518 |
91,806 |
| Total Sell Value |
$0 |
$0 |
$1,982,727 |
$7,138,305 |
| Total People Sold |
0 |
0 |
4 |
9 |
| Total Sell Transactions |
0 |
0 |
6 |
33 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Scanlan Jacqueline |
SVP, Global Human Resources |
• • – |
2021-03-08 |
4 |
S |
$120.07 |
$12,847 |
D/D |
(107) |
4,380 |
|
49% |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2021-03-08 |
4 |
S |
$120.07 |
$46,227 |
D/D |
(385) |
15,607 |
|
49% |
|
| Meelia Richard J |
Director |
• • – |
2021-02-04 |
4 |
S |
$134.64 |
$1,393,928 |
D/D |
(10,353) |
32,050 |
|
56% |
|
| Meelia Richard J |
Director |
• • – |
2021-02-04 |
4 |
OE |
$35.50 |
$367,557 |
D/D |
10,353 |
42,403 |
|
- |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2021-02-04 |
4 |
S |
$135.72 |
$362,888 |
D/D |
(2,671) |
1,511 |
|
56% |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2021-02-04 |
4 |
OE |
$34.21 |
$143,372 |
D/D |
2,433 |
2,249 |
|
- |
|
| Dockendorff Charles J |
Director |
• • – |
2021-02-04 |
4 |
S |
$134.53 |
$1,638,575 |
D/D |
(12,180) |
13,755 |
|
56% |
|
| Dockendorff Charles J |
Director |
• • – |
2021-02-04 |
4 |
OE |
$35.50 |
$432,420 |
D/D |
12,180 |
25,935 |
|
- |
|
| Simon Christopher |
President & CEO |
• • – |
2020-12-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
194,369 |
170,941 |
|
- |
|
| Burke Willaim P |
EVP, Chief Financial Officer |
• • – |
2020-10-26 |
4 |
S |
$106.00 |
$123,066 |
D/D |
(1,161) |
11,337 |
|
-12% |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2020-10-26 |
4 |
S |
$106.00 |
$10,600 |
D/D |
(100) |
1,749 |
|
-12% |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2020-10-23 |
4 |
S |
$106.58 |
$19,291 |
D/D |
(181) |
15,992 |
|
-12% |
|
| Llorens Josep |
SVP, Global Manufacturing |
• • – |
2020-09-08 |
4 |
S |
$88.71 |
$8,960 |
D/D |
(101) |
4,254 |
|
-37% |
|
| Abernathy Robert E |
Director |
• • – |
2020-08-11 |
4 |
B |
$80.93 |
$323,720 |
D/D |
4,000 |
12,048 |
2.39 |
50% |
|
| Abernathy Robert E |
Director |
• • – |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,983 |
8,048 |
|
- |
|
| Coyle Michael J |
Director |
• • – |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,983 |
2,461 |
|
- |
|
| Dockendorff Charles J |
Director |
• • – |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,983 |
13,755 |
|
- |
|
| Burzik Catherine M |
Director |
• • – |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,983 |
13,738 |
|
- |
|
| Kroll Mark W |
Director |
• • – |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,983 |
20,401 |
|
- |
|
| Zane Ellen M |
Director |
• • – |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,983 |
6,440 |
|
- |
|
| Meelia Richard J |
Director |
• • – |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,983 |
32,050 |
|
- |
|
| Pomeroy Claire |
Director |
• • – |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,983 |
3,939 |
|
- |
|
| Simon Christopher |
President & CEO |
• • – |
2020-06-30 |
4 |
S |
$87.79 |
$446,324 |
D/D |
(5,084) |
365,310 |
|
-22% |
|
| Scanlan Jacqueline |
SVP, Global Human Resources |
• • – |
2020-06-16 |
4 |
AS |
$91.53 |
$628,720 |
D/D |
(6,869) |
4,487 |
|
18% |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2020-06-16 |
4 |
AS |
$91.53 |
$278,251 |
D/D |
(3,040) |
1,849 |
|
18% |
|
1310 Records found
|
|
Page 7 of 53 |
|
|
0.45 (0.49%) 
